EN    EN  
 EUROPEAN  
COMMISSION 
Brussels, XXX   
SANTE/10374/2015 
(POOL/E3/2015/10374/10374-EN.doc) 
[…](2015) XXX  draft 
  
COMMISSION IMPLEMENTING DECISION (EU) …/… 
of XXX  
not approving triflumuron as an existing acti ve substance for use in biocidal products 
for product-type 18 
(Text with EEA relevance) 
  
EN 2   EN COMMISSION IMPLEMENTING DECISION (EU) …/… 
of XXX  
not approving triflumuron as an existing acti ve substance for use in biocidal products 
for product-type 18 
(Text with EEA relevance) 
THE EUROPEAN COMMISSION, 
Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the 
Council of 22 May 2012 concerning the making av ailable on the market and use of biocidal 
products
1, and in particular the third subpa ragraph of Article 89(1) thereof, 
Whereas: (1) Commission Delegated Regul ation (EU) No 1062/2014
2 establishes a list of existing 
active substances to be evaluated for thei r possible approval for use in biocidal 
products. That list in cludes triflumuron. 
(2) Triflumuron has been evaluated in accordan ce with Article 16(2) of Directive 98/8/EC 
of the European Parliament and of the Council3 for use in product-type 18, 
insecticides, acaricides and products to control other arthropods, as defined in 
Annex V to that Directive, which corre spond respectively to  product-type 18, as 
defined in Annex V to Regulation (EU) No 528/2012. 
(3) Italy was designated as evaluating compet ent authority and submitted the assessment 
reports, together with its recommendati ons, to the Commission on 30 September 2008 
in accordance with paragraphs 4 and 6 of  Article 14 of Commission Regulation (EC) 
No 1451/20074. 
(4) In accordance with Article 7(1)(b) of Delegated Regulation (EU) No 1062/2014, the 
opinion of the European Chemicals Agency  was formulated on 3 February 2015 by the 
Biocidal Product Committee, having regard to the conclusions of the evaluating 
competent authority.  
(5) According to that opinion, bi ocidal products used for produc t-types 18 and containing 
triflumuron may not be expected to satisfy the requirements laid down in Article 5 of 
Directive 98/8/EC. The scenarios evaluate d in the environmental risk assessment 
identified unacceptable risks for the a quatic and terrestrial compartments. 
                                                 
1 OJ L 167, 27.6.2012, p. 1. 
2 Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for 
the systematic examination of all existing active substan ces contained in biocidal products referred to in 
Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 294, 10.10.2014, 
p. 1). 
3 Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the 
placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1). 
4 Commission Regulation (EC) No 1451/2007 of 4 Decem ber 2007 on the second phase of the 10-year 
work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of 
the Council concerning the placing of biocidal products on the market (OJ L 325, 11.12.2007, p. 3).  
EN 3   EN (6) It is therefore not appropriat e to approve triflumuron for use in biocidal products for 
product-type 18.  
(7) The measures provided for in this Decision are in accordance with the opinion of the 
Standing Committee on Biocidal Products, 
HAS ADOPTED THIS DECISION:  
Article 1 
Triflumuron is not approved as an active substance for use in biocidal products for product-
type 18. 
Article 2 
This Decision shall enter into force on the twen tieth day following that of its publication in 
the Official Journal of  the European Union . 
Done at Brussels, 
 For the Commission 
 The President  Jean-Claude JUNCKER